We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

24 Feb 2017 07:06

RNS Number : 7686X
Royal Bank of Scotland Group PLC
24 February 2017
 

24 February 2017

The Royal Bank of Scotland Group plc 

LEI: 2138005O9XJIJN4JPN90

Board Appointment

The Royal Bank of Scotland Group plc ("RBS") announces today that Mark Seligman has been appointed as a Non-executive Director of RBS with effect from 1 April 2017.

Howard Davies, Chairman of RBS, said:

"Mark will bring a range of skills and expertise to the RBS Board and I am delighted he has agreed to join us. A former senior investment banker with broad financial services knowledge, Mark also has substantial FTSE 100 Board experience gained in various industry sectors, including as a Committee Chair and Senior Independent Director. I look forward to working with him".

Mr Seligman is currently Senior Independent Director of Kingfisher plc, and a Non-Executive Director of Smiths Group plc. He has previously served as a Non-Executive Director of BG Group plc and as Deputy Chairman of G4S plc

 

During his executive career, Mr Seligman held various senior roles at Credit Suisse/BZW (including Deputy Chairman, CSFB Europe and Chairman, UK Investment Banking, CSFB); and previously SG Warburg (ultimately as Managing Director, Head of Advisory).

 

There are no other matters requiring disclosure under Listing Rule 9.6.13.

For further information contact:

RBS Media Centre +44 131 523 4205

 

 

 

 

 

Notes to Editors

Biographical Details

Mark Seligman

Born in London, Mark Seligman (61) graduated from Oxford University with a MA in Philosophy, Politics and Economics and then trained as an accountant with Price Waterhouse. After qualifying in 1980 he joined Chloride Group plc as a financial analyst, before taking a role in the corporate finance department at SG Warburg & Co Ltd.

Mark spent 12 years at SG Warburg, ultimately as Managing Director, Head of Advisory. In 1995 Mark joined BZW as Joint Head of Corporate Finance, and in 1996 became Head of UK Investment Banking Credit Suisse First Boston ("CSFB"), following its acquisition of BZW.

In 1999 Mark became Deputy Chairman, CSFB Europe and, in 2003, Chairman, UK investment Banking. In 2005 Mark became a Senior Adviser at Credit Suisse in order to develop his non-executive portfolio, a role he held until 2011.

In 2006 Mark became a Non-Executive Director of G4S plc. He was appointed as Chairman of the Audit Committee in 2009, and then in 2011 he became Deputy Chairman, a role he held until stepping down in 2015.

Mark joined the Board of BG Group plc in 2009 and a year later became Audit Committee Chairman. Mark's role on the BG Group plc Board ended in February 2016, following completion of the acquisition of BG Group plc by Royal Dutch Shell plc.

In 2012 Mark was appointed Senior Independent Director at Kingfisher plc.

Mark joined the Board of Smiths Group plc as a Non-Executive Director in 2016.

Mark also serves as an alternate member of the Panel on Takeovers and Mergers.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUGDDSDDBGRS
Date   Source Headline
31st Jan 20185:12 pmRNSTotal Voting Rights
29th Jan 20182:27 pmRNSDirector/PDMR Shareholding
3rd Jan 20185:05 pmRNSPublication of Suppl.Prospcts
29th Dec 20171:20 pmRNSDirector/PDMR Shareholding
29th Dec 20171:20 pmRNSTotal Voting Rights
21st Dec 201710:14 amRNSSegmental Reporting Restatement Document
21st Dec 20179:00 amRNSDirectorate Change
7th Dec 20175:23 pmRNSPublication of a Prospectus
30th Nov 20173:29 pmRNSTotal Voting Rights
29th Nov 201711:51 amRNSHolding(s) in Company
28th Nov 20177:06 amRNS2017 Bank of England Stress Test Results
23rd Nov 20175:00 pmRNSDividend Declaration
21st Nov 20173:53 pmRNSUpdate on Ring-Fencing Plans
8th Nov 20174:34 pmRNSHolding(s) in Company
8th Nov 20173:28 pmRNSDirector/PDMR Shareholding
8th Nov 20172:40 pmRNSHolding(s) in Company
3rd Nov 201711:55 amRNSHolding(s) in Company
31st Oct 20171:41 pmRNSTotal Voting Rights
27th Oct 20174:17 pmRNSPublication of Suppl.Prospcts
27th Oct 20177:00 amRNSQ3 2017 Interim Management Statement
26th Oct 20172:13 pmRNSHolding(s) in Company
25th Oct 20171:53 pmRNSHolding(s) in Company
24th Oct 20175:37 pmRNSDisposal of shareholdings in Euroclear plc
24th Oct 20171:35 pmRNSHolding(s) in Company
24th Oct 201712:56 pmRNSHolding(s) in Company
20th Oct 201712:03 pmRNSHolding(s) in Company
17th Oct 20171:42 pmRNSHolding(s) in Company
10th Oct 20175:11 pmRNSNotices of Redemption
5th Oct 201712:24 pmRNSBlock listing Interim Review
29th Sep 20172:39 pmRNSTotal Voting Rights
29th Sep 20171:55 pmRNSThe Royal Bank of Scotland N.V. Interim Results
27th Sep 20176:20 pmRNSAllotment and Issue of New Ordinary Shares
26th Sep 20179:00 amRNSBank of America Merrill Lynch Conference
18th Sep 20175:15 pmRNSEC formally approves Alternative Remedies Package
18th Sep 20171:17 pmRNSHolding(s) in Company
14th Sep 20173:19 pmRNSHolding(s) in Company
11th Sep 20171:30 pmRNSBarclays Global Financial Services Conference
1st Sep 20172:35 pmRNSDirectorate Change
31st Aug 20179:50 amRNSTotal Voting Rights
23rd Aug 20176:11 pmRNSDividend Declaration
7th Aug 20175:43 pmRNSNotice of Redemption
7th Aug 20172:21 pmRNSPublication of Suppl.Prospcts
7th Aug 20177:00 amRNSRedemption of Non-cumulative Dollar Pref. Shares
4th Aug 20174:48 pmRNSRedemption of Non-cumulative Preference Shares
4th Aug 20177:20 amRNSTechnology & Innovation Committee
4th Aug 20177:00 amRNSHalf-year Report
31st Jul 20172:29 pmRNSTotal Voting Rights
26th Jul 20174:31 pmRNSUpdate on RBS's remaining State Aid obligation
12th Jul 20171:34 pmRNSSettlement reached with the FHFA re US RMBS claims
12th Jul 201711:00 amRNSTR-1 Notification of Major Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.